Samsung Biologics Co. is seeking to raise about 3 trillion won ($2. 2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-08-28/samsung-biologics-to-raise-2-2-billion-to-fund-polypeptide-deal)